The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point

被引：61

作者：

Chen, M. ^{[1
]}

Zhang, J. ^{[1
]}

Wang, Y. ^{[1
]}

Liu, Z. ^{[1
]}

Kelly, R. ^{[1
]}

Zhou, G. ^{[1
]}

Fang, H. ^{[2
]}

Borlak, J. ^{[3
]}

Tong, W. ^{[1
]}

机构：

[1] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA

[2] US FDA, Natl Ctr Toxicol Res, Off Sci Coordinat, Jefferson, AR 72079 USA

[3] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷 / 05期

关键词：

INJURY;

D O I：

10.1038/clpt.2013.16

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Drug-induced liver injury (DILI) is a major concern in public health management, drug development, and regulatory implementation. The Liver Toxicity Knowledge Base (LTKB) was developed with the specific aim of enhancing our understanding of DILI. It seeks to achieve improvement in DILI prediction through integrated analysis of diverse sources of drug-elicited data. The project has also produced a centralized resource of data as well as predictive models that will be useful for research and drug regulation.

引用

页码：409 / 412

页数：4

共 5 条

[1] Chen M., 2012, HEPATOLOGY
[2] FDA-approved drug labeling for the study of drug-induced liver injury
Chen, Minjun
Vijay, Vikrant
Shi, Qiang
Liu, Zhichao
Fang, Hong
Tong, Weida
[J]. DRUG DISCOVERY TODAY, 2011, 16 (15-16) : 697 - 703
[3] Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps)
Liu, Zhichao
Shi, Qiang
Ding, Don
Kelly, Reagan
Fang, Hong
Tong, Weida
[J]. PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (12)
[4] Wang Y., 2013, AM J PATHOL
[5] Is Toxicogenomics a More Reliable and Sensitive Biomarker than Conventional Indicators from Rats To Predict Drug-Induced Liver Injury in Humans?
Zhang, Min
Chen, Minjun
Tong, Weida
[J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (01) : 122 - 129

← 1 →